Paul M. Bunch MD , Joseph Rigdon PhD , Leon Lenchik MD , Matthew A. Gorris MD , Reese W. Randle MD
{"title":"Potential Impact of Opportunistic CT for Closing Diagnosis Gaps in Primary Hyperparathyroidism","authors":"Paul M. Bunch MD , Joseph Rigdon PhD , Leon Lenchik MD , Matthew A. Gorris MD , Reese W. Randle MD","doi":"10.1016/j.jacr.2024.09.009","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Primary hyperparathyroidism (PHPT) is underdiagnosed. Opportunistic assessment for enlarged parathyroid glands on routine CT examinations is a proposed approach to improve diagnosis. However, the proportion of at-risk patients with a relevant CT is unknown. We aimed to determine the proportion of individuals with hypercalcemia untested for PHPT who had CT examinations on which opportunistic screening could have been performed and to assess characteristics associated with imaging availability.</div></div><div><h3>Methods</h3><div>This retrospective study included adults with hypercalcemia untested for PHPT within our health system between January 2018 and December 2022. Each patient was classified as imaging available versus unavailable based on the presence of contrast-enhanced CTs including the parathyroid region performed between January 2013 and December 2022. Characteristics of these groups were compared.</div></div><div><h3>Results</h3><div>The sample comprised 10,702 patients (mean age, 57 years; 6,422 female and 4,280 male patients) with CTs available in 1,318 (12.3%). Characteristics associated with the greatest odds of available CT were Charlson Comorbidity Index ≥ 5 (odds ratio [OR] 5.29, <em>P</em> < .0001), death during the study period (OR 2.31, <em>P</em> < .0001), fatigue (OR 1.90, <em>P</em> < .0001), weakness (OR 1.60, <em>P</em> < .0001), and calcium > 12.0 mg/dL (OR 1.44, <em>P</em> < .0001). Characteristics associated with the lowest odds of available CT were age ≥ 85 years (OR 0.27, <em>P</em> < .0001), age < 35 years (OR 0.58, <em>P</em> < .0001), and chronic kidney disease (OR 0.64, <em>P</em> < .0001).</div></div><div><h3>Conclusion</h3><div>More than 12% of patients with hypercalcemia who were untested for PHPT had at least one CT that could have been used to opportunistically assess the parathyroid glands. Patients with imaging tended to have more comorbidities than those without.</div></div>","PeriodicalId":49044,"journal":{"name":"Journal of the American College of Radiology","volume":"22 3","pages":"Pages 376-385"},"PeriodicalIF":4.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American College of Radiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1546144024008263","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
Primary hyperparathyroidism (PHPT) is underdiagnosed. Opportunistic assessment for enlarged parathyroid glands on routine CT examinations is a proposed approach to improve diagnosis. However, the proportion of at-risk patients with a relevant CT is unknown. We aimed to determine the proportion of individuals with hypercalcemia untested for PHPT who had CT examinations on which opportunistic screening could have been performed and to assess characteristics associated with imaging availability.
Methods
This retrospective study included adults with hypercalcemia untested for PHPT within our health system between January 2018 and December 2022. Each patient was classified as imaging available versus unavailable based on the presence of contrast-enhanced CTs including the parathyroid region performed between January 2013 and December 2022. Characteristics of these groups were compared.
Results
The sample comprised 10,702 patients (mean age, 57 years; 6,422 female and 4,280 male patients) with CTs available in 1,318 (12.3%). Characteristics associated with the greatest odds of available CT were Charlson Comorbidity Index ≥ 5 (odds ratio [OR] 5.29, P < .0001), death during the study period (OR 2.31, P < .0001), fatigue (OR 1.90, P < .0001), weakness (OR 1.60, P < .0001), and calcium > 12.0 mg/dL (OR 1.44, P < .0001). Characteristics associated with the lowest odds of available CT were age ≥ 85 years (OR 0.27, P < .0001), age < 35 years (OR 0.58, P < .0001), and chronic kidney disease (OR 0.64, P < .0001).
Conclusion
More than 12% of patients with hypercalcemia who were untested for PHPT had at least one CT that could have been used to opportunistically assess the parathyroid glands. Patients with imaging tended to have more comorbidities than those without.
目的原发性甲状旁腺功能亢进症(PHPT)的诊断不足。在常规CT检查中对甲状旁腺肿大的机会性评估是提高诊断的一种方法。然而,有相关CT检查的高危患者比例尚不清楚。我们的目的是确定未进行PHPT检测的高钙血症患者的比例,这些患者进行了CT检查,可以进行机会性筛查,并评估与成像有效性相关的特征。方法本回顾性研究纳入了2018年1月至2022年12月在我国卫生系统内未经PHPT检测的高钙血症成人。根据2013年1月至2022年12月期间进行的包括甲状旁腺区域在内的对比增强ct的存在,将每位患者分为可用成像和不可成像。比较两组患者的特点。结果共纳入10702例患者,平均年龄57岁;6422名女性和4280名男性患者),其中1318名(12.3%)有ct。与可用CT的最大几率相关的特征是Charlson合并症指数≥5(比值比[OR] 5.29, P <;0.0001),研究期间的死亡率(OR 2.31, P <;.0001),疲劳(OR 1.90, P <;0.0001),疲软(OR 1.60, P <;.0001),钙>;12.0 mg/dL (OR 1.44, P <;。)。与可用CT最低几率相关的特征是年龄≥85岁(OR 0.27, P <;.0001),年龄<;35年(OR 0.58, P <;0.0001),慢性肾脏疾病(OR 0.64, P <;。)。结论:超过12%未进行PHPT检查的高钙血症患者至少有一个CT可用于评估甲状旁腺。有影像学检查的患者往往比没有影像学检查的患者有更多的合并症。
期刊介绍:
The official journal of the American College of Radiology, JACR informs its readers of timely, pertinent, and important topics affecting the practice of diagnostic radiologists, interventional radiologists, medical physicists, and radiation oncologists. In so doing, JACR improves their practices and helps optimize their role in the health care system. By providing a forum for informative, well-written articles on health policy, clinical practice, practice management, data science, and education, JACR engages readers in a dialogue that ultimately benefits patient care.